Els Van Nieuwenhuysen

10PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 14, 2026
Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG Survey.

Desislava Dimitrova, Eleftherios Pierre Samartzis, Dario Zocholl

|Jan 08, 2026
Real-life data on clinical characteristics, treatments and outcomes of patients with newly diagnosed advanced-stage ovarian cancer: an observational study from Belgium.

Els Van Nieuwenhuysen, Stephanie Henry, Katoo Muylle

|May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.

Nicole Concin, Ioana Braicu, Pierre Combe

|Oct 07, 2024
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer.

Rachel Grisham, Bradley J Monk, Els Van Nieuwenhuysen

|May 25, 2024
Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer-What Can We Learn from Breast Cancer?

Tine Ottenbourgs, Els Van Nieuwenhuysen

|Mar 07, 2024
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.

Tine Ottenbourgs, Toon van Gorp, Frédéric Kridelka

Pageof 2

Frequent Collaborators

3 joint publications

Jalid Sehouli

2 joint publications

Toon Van Gorp

2 joint publications

Regina Berger

2 joint publications

Sileny N Han